|
GS185131: GO:0044699 single-organism process
|
|
GS207306: GO:0080134 regulation of response to stress
|
|
GS197164: GO:0046328 regulation of JNK cascade
|
|
GS162992: MP:0008441 thin cortical plate
|
|
GS193153: GO:0032947 protein complex scaffold
|
|
GS136704: systemic lupus erythmatosus suppressor 1 (Sles1, Published QTL Chr 17)
|
|
GS191565: GO:0060090 binding, bridging
|
|
GS165139: MP:0003005 abnormal hippocampal fimbria morphology
|
|
GS136392: organ weight 10 (Org10, Published QTL Chr 17)
|
|
GS191149: GO:0007411 axon guidance
|
|
GS169830: MP:0005384 cellular phenotype
|
|
GS194477: GO:0019894 kinesin binding
|
|
GS182852: GO:0005198 structural molecule activity
|
|
GS167089: MP:0003232 abnormal forebrain development
|
|
GS188372: GO:0043506 regulation of JUN kinase activity
|
|
GS135641: circadian photosensitivity 2 (Circp2, Published QTL Chr 17)
|
|
GS202940: GO:0006935 chemotaxis
|
|
GS178879: GO:0030324 lung development
|
|
GS199388: GO:0019901 protein kinase binding
|
|
GS136305: modifier of Yaa 2 (Myaa2, Published QTL Chr 17)
|
|
GS181949: GO:0043406 positive regulation of MAP kinase activity
|
|
GS170021: MP:0011087 complete neonatal lethality
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS180879: GO:0051247 positive regulation of protein metabolic process
|
|
GS136509: particle-induced immune disfunction (Pidys, Published QTL Chr 17)
|
|
GS165643: MP:0011088 partial neonatal lethality
|
|
GS136170: leishmaniasis resistance 7 (Lmr7, Published QTL Chr 17)
|
|
GS184324: GO:0010646 regulation of cell communication
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS177265: GO:0048731 system development
|
|
GS201251: GO:0044424 intracellular part
|
|
GS193238: GO:0031323 regulation of cellular metabolic process
|
|
GS163837: MP:0008026 abnormal brain white matter morphology
|
|
GS178359: GO:0071840 cellular component organization or biogenesis
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS188142: GO:0048856 anatomical structure development
|
|
GS165874: MP:0002133 abnormal respiratory system physiology
|
|
GS165368: MP:0002270 abnormal pulmonary alveolus morphology
|
|
GS170243: MP:0011085 complete postnatal lethality
|
|
GS183543: GO:0051179 localization
|
|
GS168554: MP:0003115 abnormal respiratory system development
|
|
GS178357: GO:0071842 cellular component organization at cellular level
|
|
GS135227: anticardiolipin antibody 1 (Acla1, Published QTL Chr 17)
|
|
GS205500: GO:0071944 cell periphery
|
|
GS183080: GO:0033674 positive regulation of kinase activity
|
|
GS189485: GO:0023051 regulation of signaling
|
|
GS182591: GO:0019900 kinase binding
|
|
GS135736: delta power in slow-wave sleep 3 (Dps3, Published QTL Chr 17)
|
|
GS189561: GO:0001934 positive regulation of protein phosphorylation
|
|
GS210098: GO:0032947 protein complex scaffold
|
|
GS179236: GO:0048699 generation of neurons
|
|
GS197017: GO:0032990 cell part morphogenesis
|
|
GS166811: MP:0001953 respiratory failure
|
|
GS135650: cocaine induced activation 13 (Cocia13, Published QTL Chr 17)
|
|
GS201125: GO:0009790 embryo development
|
|
GS178284: GO:0031090 organelle membrane
|
|
GS207285: GO:0032872 regulation of stress-activated MAPK cascade
|
|
GS178810: GO:0051338 regulation of transferase activity
|
|
GS135556: CD8 memory T cell subset 5 (Cd8mts5, Published QTL Chr 17)
|
|
GS127931: Olfactory bulb - Allen Mouse Brain Atlas
|
|
GS188757: GO:0009887 organ morphogenesis
|
|
GS205228: GO:0043506 regulation of JUN kinase activity
|
|
GS198240: GO:0031399 regulation of protein modification process
|
|
GS163907: MP:0009770 abnormal optic chiasm morphology
|
|
GS196080: GO:0040011 locomotion
|
|
GS209082: GO:0035591 signaling adaptor activity
|
|
GS189072: GO:0043408 regulation of MAPK cascade
|
|
GS168039: MP:0000792 abnormal cortical marginal zone morphology
|
|
GS136120: body length 9 (Lgth9, Published QTL Chr 17)
|
|
GS201367: GO:0019538 protein metabolic process
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS194234: GO:0033267 axon part
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS178913: GO:0042221 response to chemical stimulus
|
|
GS186744: GO:0043226 organelle
|
|
GS198782: GO:0044459 plasma membrane part
|
|
GS182835: GO:0005622 intracellular
|
|
GS205439: GO:0031175 neuron projection development
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS203482: GO:0044093 positive regulation of molecular function
|
|
GS203406: GO:0009653 anatomical structure morphogenesis
|
|
GS205302: GO:0000139 Golgi membrane
|
|
GS180225: GO:0051403 stress-activated MAPK cascade
|
|
GS127934: Retrohippocampal region - Allen Mouse Brain Atlas
|
|
GS136437: platelet-binding antibody-associated thrombocytopenia 1 (Pbat1, Published QTL Chr 17)
|
|
GS177870: GO:0008092 cytoskeletal protein binding
|
|
GS136265: modifier of mammary tumor progression 2 (Mmtp2, Published QTL Chr 17)
|
|
GS192347: GO:0010627 regulation of intracellular protein kinase cascade
|
|
GS184448: GO:0044425 membrane part
|
|
GS207210: GO:0035295 tube development
|
|
GS192628: GO:0048666 neuron development
|
|
GS179519: GO:0012505 endomembrane system
|
|
GS186301: GO:0031401 positive regulation of protein modification process
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS136482: plasmacytoma susceptibility 4 (Pcyts4, Published QTL Chr 17)
|
|
GS209525: GO:0032989 cellular component morphogenesis
|
|
GS200341: GO:0051179 localization
|
|
GS188373: GO:0043507 positive regulation of JUN kinase activity
|
|
GS177110: GO:0030673 axolemma
|
|
GS197222: GO:0031435 mitogen-activated protein kinase kinase kinase binding
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS166590: MP:0002873 normal phenotype
|
|
GS196034: GO:0031253 cell projection membrane
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS191212: GO:0009605 response to external stimulus
|
|
GS136021: hematopoietic stem cell frequency regulator (Hscfr, Published QTL Chr 17)
|
|
GS181473: GO:0005488 binding
|
|
GS197801: GO:0007420 brain development
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS187237: GO:0030182 neuron differentiation
|
|
GS195710: GO:0032268 regulation of cellular protein metabolic process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS195594: GO:0010562 positive regulation of phosphorus metabolic process
|
|
GS170452: MP:0010860 abnormal anterior commissure pars posterior morphology
|
|
GS207616: GO:0016020 membrane
|
|
GS198004: GO:0007399 nervous system development
|
|
GS195566: GO:0051338 regulation of transferase activity
|
|
GS136429: pulmonary adenoma susceptibility 2 (Pas2, Published QTL Chr 17)
|
|
GS191779: GO:2000026 regulation of multicellular organismal development
|
|
GS202125: GO:0030424 axon
|
|
GS164264: MP:0002082 postnatal lethality
|
|
GS204746: GO:0080090 regulation of primary metabolic process
|
|
GS167360: MP:0002200 abnormal brain ventricle/choroid plexus morphology
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS182453: GO:0032147 activation of protein kinase activity
|
|
GS194295: GO:0048286 lung alveolus development
|
|
GS163161: MP:0002961 abnormal axon guidance
|
|
GS199651: GO:0005198 structural molecule activity
|
|
GS209284: GO:0010627 regulation of intracellular protein kinase cascade
|
|
GS168606: MP:0000778 abnormal nervous system tract morphology
|
|
GS209199: GO:0007165 signal transduction
|
|
GS127938: Striatum - Allen Mouse Brain Atlas
|
|
GS178838: GO:0010562 positive regulation of phosphorus metabolic process
|
|
GS177598: GO:0043412 macromolecule modification
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS196816: GO:0008432 JUN kinase binding
|
|
GS129164: progressive hearing loss 1 (Phl1 Published QTL Chr 17)
|
|
GS35078: Striatum Gene expression correlates of Difference in time on rotarod between training and saline in Females & Males BXD
|
|
GS163006: MP:0010900 abnormal pulmonary interalveolar septum morphology
|
|
GS197087: GO:0016310 phosphorylation
|
|
GS204901: GO:0071902 positive regulation of protein serine/threonine kinase activity
|
|
GS181450: GO:0031399 regulation of protein modification process
|
|
GS188506: GO:0010467 gene expression
|
|
GS196587: GO:0006468 protein phosphorylation
|
|
GS208012: GO:0044464 cell part
|
|
GS201252: GO:0044425 membrane part
|
|
GS186430: GO:0007243 intracellular protein kinase cascade
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS200867: GO:0043085 positive regulation of catalytic activity
|
|
GS168037: MP:0000798 abnormal frontal lobe morphology
|
|
GS865: Sey_Pax6_Age_Reduced_Linear_Incr
|
|
GS181032: GO:0001701 in utero embryonic development
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS205416: GO:0042325 regulation of phosphorylation
|
|
GS195607: GO:0070302 regulation of stress-activated protein kinase signaling cascade
|
|
GS136758: soft tissue heal 11 (Stheal11, Published QTL Chr 17)
|
|
GS205229: GO:0043507 positive regulation of JUN kinase activity
|
|
GS123554: vinclozolin interacting genes (MeSH:C025643) in CTD
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS208340: GO:0007257 activation of JUN kinase activity
|
|
GS205144: GO:0048468 cell development
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS204425: GO:0048812 neuron projection morphogenesis
|
|
GS136962: weight adult 4 (Wta4, Published QTL Chr 17)
|
|
GS177738: GO:0019894 kinesin binding
|
|
GS196002: GO:0048699 generation of neurons
|
|
GS168038: MP:0000794 abnormal parietal lobe morphology
|
|
GS127928: Lateral septal complex - Allen Mouse Brain Atlas
|
|
GS199635: GO:0005622 intracellular
|
|
GS14891: Upregulated genes in five combined brain regions, Amyg, HP, NA, PFC and VTA, in C57BL/6J mice
|
|
GS184271: GO:0005790 smooth endoplasmic reticulum
|
|
GS136043: insulin dependent diabetes susceptibility 16 (Idd16, Published QTL Chr 17)
|
|
GS127935: Striatum dorsal region - Allen Mouse Brain Atlas
|
|
GS178314: GO:0044304 main axon
|
|
GS164676: MP:0004267 abnormal optic tract morphology
|
|
GS179266: GO:0031252 cell leading edge
|
|
GS163292: MP:0003091 abnormal cell migration
|
|
GS204903: GO:0071900 regulation of protein serine/threonine kinase activity
|
|
GS167917: MP:0000952 abnormal CNS glial cell morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS179265: GO:0031253 cell projection membrane
|
|
GS188290: GO:0009966 regulation of signal transduction
|
|
GS190893: GO:0030154 cell differentiation
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS136177: locomotor activity 2 (Loco2, Published QTL Chr 17)
|
|
GS201256: GO:0044422 organelle part
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS201431: GO:0005515 protein binding
|
|
GS128032: Alcohol consumption QTL 9 (Alc9, Published QTL, Chr 10)
|
|
GS206192: GO:0048583 regulation of response to stimulus
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS195063: GO:0044304 main axon
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS210181: GO:0031325 positive regulation of cellular metabolic process
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS135576: cystic fibrosis lung disease 3 (Cfld3, Published QTL Chr 17)
|
|
GS167732: MP:0010825 abnormal lung saccule morphology
|
|
GS204095: GO:0030182 neuron differentiation
|
|
GS170198: MP:0001614 abnormal blood vessel morphology
|
|
GS197391: GO:0007585 respiratory gaseous exchange
|
|
GS202124: GO:0030425 dendrite
|
|
GS195636: GO:0030323 respiratory tube development
|
|
GS188556: GO:0042325 regulation of phosphorylation
|
|
GS136400: organ weight 9 (Org9, Published QTL Chr 17)
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS184629: GO:0005515 protein binding
|
|
GS167759: MP:0000787 abnormal telencephalon morphology
|
|
GS210236: GO:0000904 cell morphogenesis involved in differentiation
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS167324: MP:0003948 abnormal gas homeostasis
|
|
GS84302: differences in cocaine responsiveness (Published QTL, Chr 17)
|
|
GS194481: GO:0019899 enzyme binding
|
|
GS164032: MP:0004811 abnormal neuron physiology
|
|
GS179263: GO:0031256 leading edge membrane
|
|
GS186488: GO:0048513 organ development
|
|
GS188558: GO:0042327 positive regulation of phosphorylation
|
|
GS170601: MP:0005621 abnormal cell physiology
|
|
GS206428: GO:0001932 regulation of protein phosphorylation
|
|
GS206430: GO:0001934 positive regulation of protein phosphorylation
|
|
GS135763: experimental allergic encephalomyelitis susceptibility 5 (Eae5, Published QTL Chr 17)
|
|
GS169836: MP:0005388 respiratory system phenotype
|
|
GS166718: MP:0002169 no abnormal phenotype detected
|
|
GS205820: GO:0033036 macromolecule localization
|
|
GS201075: GO:0005794 Golgi apparatus
|
|
GS196806: GO:0032502 developmental process
|
|
GS163101: MP:0008540 abnormal cerebrum morphology
|
|
GS181215: GO:0007399 nervous system development
|
|
GS136083: keratoconus 1 (Krcn1, Published QTL Chr 17)
|
|
GS202877: GO:0005078 MAP-kinase scaffold activity
|
|
GS192629: GO:0048667 cell morphogenesis involved in neuron differentiation
|
|
GS179822: GO:0006468 protein phosphorylation
|
|
GS136378: obesity QTL 4 (Obq4, Published QTL Chr 17)
|
|
GS181988: GO:0044459 plasma membrane part
|
|
GS136092: long bones 10 (Lbn10, Published QTL Chr 17)
|
|
GS208019: GO:0051347 positive regulation of transferase activity
|
|
GS127924: Cerebral cortex - Allen Mouse Brain Atlas
|
|
GS195615: GO:0032589 neuron projection membrane
|
|
GS164530: MP:0000801 abnormal temporal lobe morphology
|
|
GS127925: Hippocampal formation - Allen Mouse Brain Atlas
|
|
GS169062: MP:0000913 abnormal brain development
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS195069: GO:0030900 forebrain development
|
|
GS166450: MP:0011089 complete perinatal lethality
|
|
GS199032: GO:0036211 protein modification process
|
|
GS177717: GO:0051239 regulation of multicellular organismal process
|
|
GS208058: GO:0007411 axon guidance
|
|
GS188045: GO:0071900 regulation of protein serine/threonine kinase activity
|
|
GS192471: GO:0048869 cellular developmental process
|
|
GS178850: GO:0070302 regulation of stress-activated protein kinase signaling cascade
|
|
GS164446: MP:0005195 abnormal posterior eye segment morphology
|
|
GS136909: vertebral morphology and mechanical traits 14 (Vmmt14, Published QTL Chr 17)
|
|
GS184267: GO:0005794 Golgi apparatus
|
|
GS180594: GO:0007585 respiratory gaseous exchange
|
|
GS127937: Striatum-like amygdalar nuclei - Allen Mouse Brain Atlas
|
|
GS167753: MP:0000780 abnormal corpus callosum morphology
|
|
GS128599: Ethanol Induced Ataxia Chr#17
|
|
GS169531: MP:0005391 vision/eye phenotype
|
|
GS194065: GO:0016192 vesicle-mediated transport
|
|
GS183491: GO:0060284 regulation of cell development
|
|
GS136804: tibia bone quality traits 6 (Tbqt6, Published QTL Chr 17)
|
|
GS193237: GO:0031325 positive regulation of cellular metabolic process
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS184452: GO:0044422 organelle part
|
|
GS136562: radiation pulmonary fibrosis 1 (Radpf1, Published QTL Chr 17)
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS135781: early growth adjusted QTL 2 (Egaq2, Published QTL Chr 17)
|
|
GS136685: skull morphology 24 (Skull24, Published QTL Chr 17)
|
|
GS205935: GO:0043408 regulation of MAPK cascade
|
|
GS190314: GO:0035295 tube development
|
|
GS199617: GO:0060425 lung morphogenesis
|
|
GS207805: GO:0043005 neuron projection
|
|
GS135896: gastritis type A susceptibility locus 4 (Gasa4, Published QTL Chr 17)
|
|
GS84299: ethanol metabolism rate (Published QTL, Chr 17)
|
|
GS197275: GO:0033554 cellular response to stress
|
|
GS203147: GO:0031401 positive regulation of protein modification process
|
|
GS129074: alloantigen response 1 (Alan1 Published QTL Chr 17)
|
|
GS195977: GO:0007154 cell communication
|
|
GS192171: GO:0000165 MAPK cascade
|
|
GS205691: GO:0022008 neurogenesis
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS198274: GO:0035556 intracellular signal transduction
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS127939: Thalamus - Allen Mouse Brain Atlas
|
|
GS135644: cerebral malaria susceptibility in CBA/N (Cmcs, Published QTL Chr 17)
|
|
GS181950: GO:0043405 regulation of MAP kinase activity
|
|
GS193826: GO:0030673 axolemma
|
|
GS170671: MP:0010911 abnormal pulmonary acinus morphology
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS180164: GO:0008150 biological_process
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS184422: GO:0060541 respiratory system development
|
|
GS192660: GO:0051960 regulation of nervous system development
|
|
GS180237: GO:0032990 cell part morphogenesis
|
|
GS180482: GO:0033554 cellular response to stress
|
|
GS167748: MP:0000788 abnormal cerebral cortex morphology
|
|
GS181483: GO:0035556 intracellular signal transduction
|
|
GS186562: GO:0009653 anatomical structure morphogenesis
|
|
GS188578: GO:0031175 neuron projection development
|
|
GS136260: male hybrid sterility QTL 1 (Mhstq1, Published QTL Chr 17)
|
|
GS162995: MP:0008440 abnormal subplate morphology
|
|
GS179310: GO:0040011 locomotion
|
|
GS209232: GO:0006796 phosphate-containing compound metabolic process
|
|
GS127930: Midbrain - Allen Mouse Brain Atlas
|
|
GS127933: Pons - Allen Mouse Brain Atlas
|
|
GS136372: obesity QTL 19 (Obq19, Published QTL Chr 17)
|
|
GS192147: GO:0035591 signaling adaptor activity
|
|
GS177721: GO:0051234 establishment of localization
|
|
GS198743: GO:0043406 positive regulation of MAP kinase activity
|
|
GS208482: GO:0042995 cell projection
|
|
GS14929: Ethanol-dependence genes in the nucleus accumbens (NA) of inbred alcohol-preferring
|
|
GS165465: MP:0003633 abnormal nervous system physiology
|
|
GS193294: GO:0000902 cell morphogenesis
|
|
GS197670: GO:0051247 positive regulation of protein metabolic process
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS177559: GO:0048286 lung alveolus development
|
|
GS200602: GO:0044267 cellular protein metabolic process
|
|
GS196004: GO:0045859 regulation of protein kinase activity
|
|
GS193563: GO:0006950 response to stress
|
|
GS129111: chronic experimental autoimmune thyroiditis 1 (Ceat1 Published QTL Chr 17)
|
|
GS136943: weight 6 weeks QTL 11 (W6q11, Published QTL Chr 17)
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS180878: GO:0051246 regulation of protein metabolic process
|
|
GS204996: GO:0048858 cell projection morphogenesis
|
|
GS164220: MP:0002882 abnormal neuron morphology
|
|
GS124648: Lipopolysaccharides interacting genes (MeSH:D008070) in CTD
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS166217: MP:0010859 abnormal anterior commissure pars anterior morphology
|
|
GS201949: GO:0044699 single-organism process
|
|
GS170738: MP:0001056 abnormal cranial nerve morphology
|
|
GS187749: GO:0019220 regulation of phosphate metabolic process
|
|
GS83971: cocaine induced activation 3 (Cocia3, Published QTL, Chr 17)
|
|
GS188641: GO:0071944 cell periphery
|
|
GS185910: GO:0000187 activation of MAPK activity
|
|
GS209569: GO:0048667 cell morphogenesis involved in neuron differentiation
|
|
GS135590: P. chabaudi malaria resistance QTL 3 (Char3, Published QTL Chr 17)
|
|
GS164320: MP:0003861 abnormal nervous system development
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS136833: trypanosome infection response 1 (Tir1, Published QTL Chr 17)
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS135229: Angiostrongylus costaricensis nematode susceptibility 3 (Acsns3, Published QTL Chr 17)
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS199251: GO:0032147 activation of protein kinase activity
|
|
GS210507: GO:0006950 response to stress
|
|
GS203276: GO:0007243 intracellular protein kinase cascade
|
|
GS179830: GO:0006464 cellular protein modification process
|
|
GS193268: GO:0005575 cellular_component
|
|
GS127923: Cerebellum - Allen Mouse Brain Atlas
|
|
GS200986: GO:0032270 positive regulation of cellular protein metabolic process
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS201869: GO:0008104 protein localization
|
|
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS190494: GO:0007254 JNK cascade
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS196595: GO:0006464 cellular protein modification process
|
|
GS210237: GO:0000902 cell morphogenesis
|
|
GS201132: GO:0010646 regulation of cell communication
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS180043: GO:0008432 JUN kinase binding
|
|
GS191106: GO:0044464 cell part
|
|
GS182095: GO:0080135 regulation of cellular response to stress
|
|
GS177570: GO:0016043 cellular component organization
|
|
GS192584: GO:0032989 cellular component morphogenesis
|
|
GS180431: GO:0031435 mitogen-activated protein kinase kinase kinase binding
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS136226: mandible length 18 (Manln18, Published QTL Chr 17)
|
|
GS168603: MP:0000774 decreased brain size
|
|
GS136157: leishmaniasis resistance 1 (Lmr1, Published QTL Chr 17)
|
|
GS185054: GO:0008104 protein localization
|
|
GS198887: GO:0080135 regulation of cellular response to stress
|
|
GS191416: GO:0007257 activation of JUN kinase activity
|
|
GS186107: GO:0006935 chemotaxis
|
|
GS135462: bleomycin pulmonary fibrosis 1 (Bplpf1, Published QTL Chr 17)
|
|
GS192944: GO:0050767 regulation of neurogenesis
|
|
GS180432: GO:0031434 mitogen-activated protein kinase kinase binding
|
|
GS188446: GO:0000139 Golgi membrane
|
|
GS164133: MP:0005076 abnormal cell differentiation
|
|
GS181011: GO:0007420 brain development
|
|
GS168579: MP:0003635 abnormal synaptic transmission
|
|
GS125670: pyrimidin-2-one beta-ribofuranoside interacting genes (MeSH:C009131) in CTD
|
|
GS136933: vertebral trabecular bone trait 18 (Vtbt18, Published QTL Chr 17)
|
|
GS83968: cocaine induced activation 13 (Cocia13, Published QTL, Chr 17)
|
|
GS188136: GO:0048858 cell projection morphogenesis
|
|
GS14889: Differentially expressed genes modulated by nicotine in five combined brain regions (Amyg, HP, NA, PFC and VTA) for C57BL/6J mice
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS169817: MP:0010899 abnormal pulmonary alveolar system morphology
|
|
GS177499: GO:0033267 axon part
|
|
GS187708: GO:0009893 positive regulation of metabolic process
|
|
GS196726: GO:0005783 endoplasmic reticulum
|
|
GS84300: METH responses for body temperature (Published QTL, Chr 17)
|
|
GS136887: UVB induced immunosuppression 2 (Uvbi2, Published QTL Chr 17)
|
|
GS169946: MP:0000825 dilated lateral ventricles
|
|
GS168502: MP:0002058 neonatal lethality
|
|
GS189388: GO:0016301 kinase activity
|
|
GS167565: MP:0001177 atelectasis
|
|
GS189748: GO:0050790 regulation of catalytic activity
|
|
GS169646: MP:0000934 abnormal telencephalon development
|
|
GS135256: adenovirus induced hyperthyroidism 2 (Advh2, Published QTL Chr 17)
|
|
GS196284: GO:0012505 endomembrane system
|
|
GS188482: GO:0051094 positive regulation of developmental process
|
|
GS189484: GO:0023052 signaling
|
|
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS201227: GO:0060541 respiratory system development
|
|
GS135861: femur breaking strength 4 (Fembrs4, Published QTL Chr 17)
|
|
GS184317: GO:0009790 embryo development
|
|
GS127926: Hippocampal region - Allen Mouse Brain Atlas
|
|
GS188750: GO:0044431 Golgi apparatus part
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS178878: GO:0030323 respiratory tube development
|
|
GS135331: autoimmune susceptibility in C57BL/6J and BALB/c 3 (Asbb3, Published QTL Chr 17)
|
|
GS194613: GO:0008092 cytoskeletal protein binding
|
|
GS127932: Pallidum - Allen Mouse Brain Atlas
|
|
GS166244: MP:0002752 abnormal somatic nervous system morphology
|
|
GS167755: MP:0000783 abnormal forebrain morphology
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS84301: ethanol conditioned taste aversion (Published QTL, Chr 17)
|
|
GS163342: MP:0008220 abnormal ventral commissure morphology
|
|
GS197669: GO:0051246 regulation of protein metabolic process
|
|
GS127681: Alcohol consumption QTL 5 (Alc5, Published QTL, Chr 10)
|
|
GS167656: MP:0001943 abnormal respiration
|
|
GS184318: GO:0009792 embryo development ending in birth or egg hatching
|
|
GS206329: GO:0060255 regulation of macromolecule metabolic process
|
|
GS169631: MP:0004166 abnormal limbic system morphology
|
|
GS135250: adiposity 18 (Adip18, Published QTL Chr 17)
|
|
GS201126: GO:0009792 embryo development ending in birth or egg hatching
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS187790: GO:0043549 regulation of kinase activity
|
|
GS191796: GO:0016740 transferase activity
|
|
GS201124: GO:0009791 post-embryonic development
|
|
GS136634: small effect CIA locus 8 (Secia8, Published QTL Chr 17)
|
|
GS198744: GO:0043405 regulation of MAP kinase activity
|
|
GS135782: early growth QTL 5 (Egq5, Published QTL Chr 17)
|
|
GS123117: endotoxin, Escherichia coli interacting genes (MeSH:C044101) in CTD
|
|
GS182325: GO:0051716 cellular response to stimulus
|
|
GS163704: MP:0000832 abnormal thalamus morphology
|
|
GS182699: GO:0051174 regulation of phosphorus metabolic process
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS184010: GO:0030030 cell projection organization
|
|
GS166899: MP:0001330 abnormal optic nerve morphology
|
|
GS136304: modifier of Yaa 1 (Myaa1, Published QTL Chr 17)
|
|
GS192609: GO:0031982 vesicle
|
|
GS207387: GO:0007254 JNK cascade
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS169004: MP:0008219 abnormal dorsal telencephalic commissure morphology
|
|
GS135370: B.burgdorferi-associated arthritis 8 (Bbaa8, Published QTL Chr 17)
|
|
GS204610: GO:0019220 regulation of phosphate metabolic process
|
|
GS136866: T cell receptor induced activation 3 (Tria3, Published QTL Chr 17)
|
|
GS182590: GO:0019901 protein kinase binding
|
|
GS185024: GO:0044463 cell projection part
|
|
GS193991: GO:0048731 system development
|
|
GS184252: GO:0042330 taxis
|
|
GS127929: Medulla - Allen Mouse Brain Atlas
|
|
GS190900: GO:0043009 chordate embryonic development
|
|
GS188511: GO:0010468 regulation of gene expression
|
|
GS201839: GO:0044463 cell projection part
|
|
GS205609: GO:0044431 Golgi apparatus part
|
|
GS184447: GO:0044424 intracellular part
|
|
GS26270: Hippocampus Gene expression correlates of Mechanical Sensitivity-Von Frey Threshold in Females BXD
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS206356: GO:0023051 regulation of signaling
|
|
GS178360: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS203335: GO:0048513 organ development
|
|
GS193293: GO:0000904 cell morphogenesis involved in differentiation
|
|
GS190410: GO:0080134 regulation of response to stress
|
|
GS135877: femur geometry 14 (Fmgty14, Published QTL Chr 17)
|
|
GS167698: MP:0009969 abnormal cerebral cortex pyramidal cell morphology
|
|
GS195036: GO:0031090 organelle membrane
|
|
GS188957: GO:0033036 macromolecule localization
|
|
GS164526: MP:0000807 abnormal hippocampus morphology
|
|
GS182234: GO:0036211 protein modification process
|
|
GS192138: GO:0045860 positive regulation of protein kinase activity
|
|
GS210212: GO:0005575 cellular_component
|
|
GS164123: MP:0001574 abnormal oxygen level
|
|
GS177334: GO:0016192 vesicle-mediated transport
|
|
GS205369: GO:0010468 regulation of gene expression
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS208496: GO:0060090 binding, bridging
|
|
GS168746: MP:0002199 abnormal brain commissure morphology
|
|
GS164261: MP:0002081 perinatal lethality
|
|
GS199880: GO:0033674 positive regulation of kinase activity
|
|
GS34019: Hippocampus Gene expression correlates of Open Field locomotion 45-60 min post cocaine in Females BXD
|
|
GS190899: GO:0043005 neuron projection
|
|
GS184316: GO:0009791 post-embryonic development
|
|
GS183803: GO:0044267 cellular protein metabolic process
|
|
GS129089: bronchial hyperresponsiveness 3 (Bhr3 Published QTL Chr 17)
|
|
GS177742: GO:0019899 enzyme binding
|
|
GS207807: GO:0043009 chordate embryonic development
|
|
GS196032: GO:0031256 leading edge membrane
|
|
GS165616: MP:0002127 abnormal cardiovascular system morphology
|
|
GS210376: GO:0007417 central nervous system development
|
|
GS209073: GO:0045860 positive regulation of protein kinase activity
|
|
GS182834: GO:0005623 cell
|
|
GS167563: MP:0001175 abnormal lung morphology
|
|
GS205418: GO:0042327 positive regulation of phosphorylation
|
|
GS187560: GO:0048812 neuron projection morphogenesis
|
|
GS189460: GO:0060255 regulation of macromolecule metabolic process
|
|
GS84298: cocaine induced activation (Published QTL, Chr 17)
|
|
GS164124: MP:0001575 cyanosis
|
|
GS168012: MP:0010832 lethality during fetal growth through weaning
|
|
GS185304: GO:0030424 axon
|
|
GS186180: GO:0045937 positive regulation of phosphate metabolic process
|
|
GS186043: GO:0005078 MAP-kinase scaffold activity
|
|
GS196943: GO:0008152 metabolic process
|
|
GS180305: GO:0016310 phosphorylation
|
|
GS187146: GO:0044700 single organism signaling
|
|
GS199634: GO:0005623 cell
|
|
GS164733: MP:0008439 abnormal cortical plate morphology
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS166192: MP:0009937 abnormal neuron differentiation
|
|
GS167357: MP:0002206 abnormal CNS synaptic transmission
|
|
GS167564: MP:0001176 abnormal lung development
|
|
GS197005: GO:0051403 stress-activated MAPK cascade
|
|
GS178858: GO:0032589 neuron projection membrane
|
|
GS178953: GO:0032268 regulation of cellular protein metabolic process
|
|
GS205616: GO:0009887 organ morphogenesis
|
|
GS210182: GO:0031323 regulation of cellular metabolic process
|
|
GS185303: GO:0030425 dendrite
|
|
GS163987: MP:0000822 abnormal brain ventricle morphology
|
|
GS168600: MP:0000771 abnormal brain size
|
|
GS188061: GO:0016772 transferase activity, transferring phosphorus-containing groups
|
|
GS196933: GO:0065009 regulation of molecular function
|
|
GS180206: GO:0045597 positive regulation of cell differentiation
|
|
GS195637: GO:0030324 lung development
|
|
GS165875: MP:0002132 abnormal respiratory system morphology
|
|
GS190682: GO:0007275 multicellular organismal development
|
|
GS190389: GO:0032872 regulation of stress-activated MAPK cascade
|
|
GS136861: "T cell receptor beta variable 4, control 1" (Trbv4c1, Published QTL Chr 17)
|
|
GS188043: GO:0071902 positive regulation of protein serine/threonine kinase activity
|
|
GS193432: GO:0007417 central nervous system development
|
|
GS203020: GO:0045937 positive regulation of phosphate metabolic process
|
|
GS136800: total body bone mineral density 7 (Tbbmd7, Published QTL Chr 17)
|
|
GS206620: GO:0050790 regulation of catalytic activity
|
|
GS136903: ventral midbrain iron content 9 (Vmbic9, Published QTL Chr 17)
|
|
GS180208: GO:0045595 regulation of cell differentiation
|
|
GS188826: GO:0022008 neurogenesis
|
|
GS204568: GO:0009893 positive regulation of metabolic process
|
|
GS209452: GO:0006810 transport
|
|
GS184065: GO:0043085 positive regulation of catalytic activity
|
|
GS163337: MP:0008225 abnormal anterior commissure morphology
|
|
GS178320: GO:0030900 forebrain development
|
|
GS135924: hepatocarcinogenesis in females 1 (Hcif1, Published QTL Chr 17)
|
|
GS163971: MP:0002092 abnormal eye morphology
|
|
GS179238: GO:0045859 regulation of protein kinase activity
|
|
GS194459: GO:0051234 establishment of localization
|
|
GS179211: GO:0007154 cell communication
|
|
GS188465: GO:0031410 cytoplasmic vesicle
|
|
GS192265: GO:0007165 signal transduction
|
|
GS196035: GO:0031252 cell leading edge
|
|
GS205147: GO:0009966 regulation of signal transduction
|
|
GS180152: GO:0065007 biological regulation
|
|
GS189694: GO:0045666 positive regulation of neuron differentiation
|
|
GS197223: GO:0031434 mitogen-activated protein kinase kinase binding
|
|
GS135324: antibody response to human factor IX (Arfix, Published QTL Chr 17)
|
|
GS209568: GO:0048666 neuron development
|
|
GS163671: MP:0004007 abnormal lung vasculature morphology
|
|
GS189692: GO:0045664 regulation of neuron differentiation
|
|
GS189326: GO:0048583 regulation of response to stimulus
|
|
GS127927: Hypothalamus - Allen Mouse Brain Atlas
|
|
GS208126: GO:0009605 response to external stimulus
|
|
GS186633: GO:0044093 positive regulation of molecular function
|
|
GS203594: GO:0043226 organelle
|
|
GS205364: GO:0010467 gene expression
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS202795: GO:0007409 axonogenesis
|
|
GS165137: MP:0003006 abnormal hippocampal fornix morphology
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS136773: SGC/Knj cross B6 QTL 3 (Sxbq3, Published QTL Chr 17)
|
|
GS167622: MP:0002152 abnormal brain morphology
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS163986: MP:0000823 abnormal lateral ventricle morphology
|
|
GS201060: GO:0042330 taxis
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS178288: GO:0031098 stress-activated protein kinase signaling cascade
|
|
GS135616: circulating hormone level QTL 8 (Chlq8, Published QTL Chr 17)
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS182818: GO:0060425 lung morphogenesis
|
|
GS164055: MP:0002316 anoxia
|
|
GS199389: GO:0019900 kinase binding
|
|
GS180001: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS136686: skull morphology 25 (Skull25, Published QTL Chr 17)
|
|
GS189559: GO:0001932 regulation of protein phosphorylation
|
|
GS34984: Whole Brain Gene expression correlates of Open Field - Habituation ratio (First:Last intervals) in Males BXD
|
|
GS136479: periosteal circumference 4 (Pcir4, Published QTL Chr 17)
|
|
GS194336: GO:0043412 macromolecule modification
|
|
GS180166: GO:0008152 metabolic process
|
|
GS179957: GO:0005783 endoplasmic reticulum
|
|
GS168592: MP:0003634 abnormal glial cell morphology
|
|
GS202749: GO:0000187 activation of MAPK activity
|
|
GS209105: GO:0000165 MAPK cascade
|
|
GS192509: GO:0006810 transport
|
|
GS136942: weight 10 weeks QTL 12 (W10q12, Published QTL Chr 17)
|
|
GS184182: GO:0032270 positive regulation of cellular protein metabolic process
|
|
GS127936: Striatum ventral region - Allen Mouse Brain Atlas
|
|
GS190714: GO:0016020 membrane
|
|
GS187751: GO:0019222 regulation of metabolic process
|
|
GS191113: GO:0051347 positive regulation of transferase activity
|
|
GS180380: GO:0046328 regulation of JNK cascade
|
|
GS191552: GO:0042995 cell projection
|
|
GS167938: MP:0001179 thick pulmonary interalveolar septum
|
|
GS180034: GO:0032502 developmental process
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS199124: GO:0051716 cellular response to stimulus
|
|
GS180155: GO:0065009 regulation of molecular function
|
|
GS185957: GO:0007409 axonogenesis
|
|
GS199495: GO:0051174 regulation of phosphorus metabolic process
|
|
GS197822: GO:0001701 in utero embryonic development
|
|
GS192296: GO:0006796 phosphate-containing compound metabolic process
|
|
GS198263: GO:0005488 binding
|
|
GS200809: GO:0030030 cell projection organization
|
|
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
|
|
GS206355: GO:0023052 signaling
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS164473: MP:0006009 abnormal neuronal migration
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS195041: GO:0031098 stress-activated protein kinase signaling cascade
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS204649: GO:0043549 regulation of kinase activity
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS136549: proteinuria 2 (Ptnu2, Published QTL Chr 17)
|
|
GS163706: MP:0000830 abnormal diencephalon morphology
|
|
GS168995: MP:0009642 abnormal blood homeostasis
|
|
GS188287: GO:0048468 cell development
|
|
GS189746: GO:0050793 regulation of developmental process
|
|
GS169829: MP:0005385 cardiovascular system phenotype
|
|
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS201079: GO:0005790 smooth endoplasmic reticulum
|